Below are the most recent publications written about "Antidepressive Agents" by people in Profiles.
-
Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 07; 7(7):581-601.
-
Michel CM, Pascual-Leone A. Predicting antidepressant response by electroencephalography. Nat Biotechnol. 2020 04; 38(4):417-419.
-
Wu W, Zhang Y, Jiang J, Lucas MV, Fonzo GA, Rolle CE, Cooper C, Chin-Fatt C, Krepel N, Cornelssen CA, Wright R, Toll RT, Trivedi HM, Monuszko K, Caudle TL, Sarhadi K, Jha MK, Trombello JM, Deckersbach T, Adams P, McGrath PJ, Weissman MM, Fava M, Pizzagalli DA, Arns M, Trivedi MH, Etkin A. An electroencephalographic signature predicts antidepressant response in major depression. Nat Biotechnol. 2020 04; 38(4):439-447.
-
Papakostas GI. Maintaining Rapid Antidepressant Effects Following Ketamine Infusion: A Major Unmet Need. J Clin Psychiatry. 2020 02 04; 81(2).
-
Webb CA, Cohen ZD, Beard C, Forgeard M, Peckham AD, Björgvinsson T. Personalized prognostic prediction of treatment outcome for depressed patients in a naturalistic psychiatric hospital setting: A comparison of machine learning approaches. J Consult Clin Psychol. 2020 Jan; 88(1):25-38.
-
Agboola F, Atlas SJ, Touchette DR, Fazioli K, Pearson SD. The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression. J Manag Care Spec Pharm. 2020 Jan; 26(1):16-20.
-
Sarris J, Murphy J, Stough C, Mischoulon D, Bousman C, MacDonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH, Byrne GJ. S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial. Psychopharmacology (Berl). 2020 Jan; 237(1):209-218.
-
Page S, Mavrikaki MM, Lintz T, Puttick D, Roberts E, Rosen H, Carroll FI, Carlezon WA, Chartoff EH. Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats. Int J Neuropsychopharmacol. 2019 11 01; 22(11):735-745.
-
Dotson S, Mischoulon D, Lee H, Fava M. Rising placebo response rates threaten the validity of antipsychotic meta-analyses. Ann Clin Psychiatry. 2019 11; 31(4):249-259.
-
Mischel NA, Kritzer MD, Patkar AA, Masand PS, Szabo ST. Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician. J Clin Psychopharmacol. 2019 Nov/Dec; 39(6):665-672.